Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alimera Sciences Reports Second Quarter 2024 Results
-
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
-
iSpecimen Reports Second Quarter 2024 Results
-
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
-
Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
AS Tallink Grupp: Managers’ Transactions
-
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
-
Hillman Announces Leadership Succession Plans: COO Jon Michael Adinolfi to be Appointed as Next CEO; CEO Doug Cahill to Become Executive Chairman
-
Novo Nordisk A/S - share repurchase programme
-
Tecan schedules conference call on August 13th to discuss half year 2024 financial results
-
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
-
MSHS / Pacific Power Group Announces New Marine Service Center on Lake Union
-
Asante Provides Update on Project Development and Operations
-
NorthWest Copper Publishes Annual ESG Report
-
Evergold Prepares to Drill Crucial Follow-up Holes at DEM Gold Discovery, B.C.
-
First Watch Restaurant Group, Inc. Reports Q2 2024 Financial Results
-
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
-
Xali Gold Trading Halt
-
The Eclipse Foundation Announces Agenda and Keynote Speakers for Open Community Experience (OCX 2024), Europe’s Premier Event for Open Source Innovation
-
BioXcel Therapeutics Reports Second Quarter 2024 Financial Results
-
NFI subsidiary New Flyer named as partner of choice for more than $338 million in FTA Low- or No-Emission and Buses and Bus Facilities grants
-
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options
-
American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico
-
Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
-
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Fuller Theological Seminary Announces the Launch of "The New Testament in Color"
-
Hemlo Explorers Enters Share Purchase Agreements for the Acquisition of Rocky Shore Metals and its Gold Anchor Project
-
NexGold Mining and Wabigoon Lake Ojibway Nation Sign New Relationship Agreement for Goliath Gold Complex
-
Accounting & Business Advisory Leader Clark Schaefer Hackett Chooses AI Networking with Nile
-
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
-
Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
-
Creative Realities Elevates Game Day with Innovative Digital Signage in Sports & Entertainment Venues
-
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
-
PlanSource Welcomes Jennifer Zador as General Counsel and Chief Compliance Officer
-
OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use
-
Beamr in Q2-2024: Enhancements to Beamr Cloud and Collaborations with Industry Giants
-
LeddarTech Enters Into Amendment to Credit Facility and Announces Receipt of Nasdaq Deficiency Notices
-
Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update
-
The National Minority Enterprise Development Week (MED Week) Deadline for Nominations Fast Approaching on August 15, 2024
-
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology
-
Silvaco To Present at the Rosenblatt 4th Annual Technology Summit
-
European Wax Center Announces Appointment of Julia Hunter to Board Of Directors
-
Passage Bio to Participate in Upcoming Investor Conferences
-
GlobalFoundries Reports Second Quarter 2024 Financial Results
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Second-Quarter Results
-
Fuller Theological Seminary Announces the Launch of "The New Testament in Color"
-
Creative Realities Elevates Game Day with Innovative Digital Signage in Sports & Entertainment Venues
-
SimiTree Welcomes New Industry Experts Colleen Lazar and Brittney Lovely
